DE1418594A1 - Verfahren zur Herstellung neuer basischer 1,3-Dioxane und ihrer Salze - Google Patents
Verfahren zur Herstellung neuer basischer 1,3-Dioxane und ihrer SalzeInfo
- Publication number
- DE1418594A1 DE1418594A1 DE19621418594 DE1418594A DE1418594A1 DE 1418594 A1 DE1418594 A1 DE 1418594A1 DE 19621418594 DE19621418594 DE 19621418594 DE 1418594 A DE1418594 A DE 1418594A DE 1418594 A1 DE1418594 A1 DE 1418594A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- dioxane
- salts
- dioxanes
- meaning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 title description 7
- 150000000093 1,3-dioxanes Chemical class 0.000 title description 2
- IXTNDEVVXTYVHI-UHFFFAOYSA-N 1,4-dioxan-2-amine Chemical class NC1COCCO1 IXTNDEVVXTYVHI-UHFFFAOYSA-N 0.000 claims description 6
- -1 1-phenylcyclohexyl Chemical group 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 2
- 150000002366 halogen compounds Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- SLHSRCBFPHCSGL-UHFFFAOYSA-N (3-bromo-1-phenylpropyl)benzene Chemical compound C=1C=CC=CC=1C(CCBr)C1=CC=CC=C1 SLHSRCBFPHCSGL-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- KQAQAPVOBUWGEL-UHFFFAOYSA-N C1(=CC=CC=C1)C(CCNC1OCCOC1)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)C(CCNC1OCCOC1)C1=CC=CC=C1 KQAQAPVOBUWGEL-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000004351 phenylcyclohexyl group Chemical group C1(=CC=CC=C1)C1(CCCCC1)* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0069027 | 1962-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1418594A1 true DE1418594A1 (de) | 1968-12-05 |
Family
ID=6976133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19621418594 Pending DE1418594A1 (de) | 1962-09-29 | 1962-09-29 | Verfahren zur Herstellung neuer basischer 1,3-Dioxane und ihrer Salze |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3275657A (enExample) |
| BE (1) | BE637951A (enExample) |
| CH (2) | CH444884A (enExample) |
| DE (1) | DE1418594A1 (enExample) |
| DK (3) | DK104847C (enExample) |
| GB (1) | GB981478A (enExample) |
| LU (1) | LU44520A1 (enExample) |
| NL (1) | NL298481A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2627369B1 (en) | 2010-10-15 | 2022-01-12 | SeaStar Medical, Inc. | Cytopheresic cartridge and use thereof |
| EP2802367A4 (en) * | 2012-01-09 | 2015-12-16 | H David Humes | CARTRIDGE AND METHOD FOR INCREASING THE HEART MUSCULAR FUNCTION |
-
0
- BE BE637951D patent/BE637951A/xx unknown
- NL NL298481D patent/NL298481A/xx unknown
-
1962
- 1962-09-29 DE DE19621418594 patent/DE1418594A1/de active Pending
-
1963
- 1963-09-13 US US308633A patent/US3275657A/en not_active Expired - Lifetime
- 1963-09-27 DK DK428964AA patent/DK104847C/da active
- 1963-09-27 CH CH1562366A patent/CH444884A/de unknown
- 1963-09-27 LU LU44520D patent/LU44520A1/xx unknown
- 1963-09-27 DK DK455263AA patent/DK105474C/da active
- 1963-09-27 DK DK429064AA patent/DK104942C/da active
- 1963-09-27 GB GB38186/63A patent/GB981478A/en not_active Expired
- 1963-09-27 CH CH1191563A patent/CH434291A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU44520A1 (enExample) | 1964-01-02 |
| US3275657A (en) | 1966-09-27 |
| CH434291A (de) | 1967-04-30 |
| GB981478A (en) | 1965-01-27 |
| CH444884A (de) | 1967-10-15 |
| NL298481A (enExample) | |
| DK104942C (da) | 1966-07-25 |
| DK105474C (da) | 1966-10-03 |
| BE637951A (enExample) | |
| DK104847C (da) | 1966-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1595920A1 (de) | 4-(omega-Piperazinoalkyl)-pyrazole,ihre Salze und Verfahren zu ihrer Herstellung | |
| DE1418594A1 (de) | Verfahren zur Herstellung neuer basischer 1,3-Dioxane und ihrer Salze | |
| DE955595C (de) | Verfahren zur Herstellung von spasmolytisch wirksamen basischen AEthern endocyclisch substituierter Carbinole und ihren Salzen | |
| DE942149C (de) | Verfahren zur Herstellung substituierter Glycinamide | |
| DE896810C (de) | Verfahren zur Herstellung tertiaerer Alkinamine | |
| DE2338409A1 (de) | Neues verfahren zur herstellung von 2-acylamino-benzylaminen | |
| DE1911893A1 (de) | Verfahren zur Herstellung von N-(Halogen-aryl)-2-methyl-5-alkoxy-indol-3-essigsaeuren | |
| DE1018869B (de) | Verfahren zur Herstellung von Aminoalkylpurinderivaten | |
| AT331804B (de) | Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen, deren optischen isomeren und deren salzen | |
| DE69718444T2 (de) | Neue derivate der 1(2h) chinolin-carbonsäure, verfahren zu deren herstellung und deren verwendung zur herstellung von produkten mit antibiotischen eigenschaften | |
| AT395712B (de) | Verfahren zur herstellung von neuen alkyl(1-((2-phenoxyethyl)amino)-propyliden) hydrazincarboxylaten | |
| AT211823B (de) | Verfahren zur Herstellung von neuen Aryloxyessigsäureamiden | |
| DE972617C (de) | Verfahren zur Herstellung von 5-Amino-1, 3-dioxanen | |
| DE1570034A1 (de) | Verfahren zur Herstellung von Nikotinsaeureamiden | |
| DE2311637C3 (de) | Verfahren zur Herstellung von 2-Aminobenzylaminen | |
| AT228407B (de) | Verfahren zur Herstellung neuer Ester von N-(Hydroxyalkyl)-nortropanen bzw. -norgranatanen, deren Salzen und quartären Ammoniumverbindungen | |
| AT268256B (de) | Verfahren zur Herstellung von neuen, in 4-Stellung substituierten 2-Alkoxy-5-halogenbenzoesäureestern | |
| DE2445681A1 (de) | Verfahren zur herstellung von 3-phenylpyridazonen | |
| DE926848C (de) | Verfahren zur Herstellung von Derivaten des Cumarans | |
| AT234691B (de) | Verfahren zur Herstellung von neuen Piperidinderivaten | |
| AT303732B (de) | Verfahren zur herstellung von phenylbutan-1-olen bzw. von saeureadditionssalzen dieser verbindungen | |
| AT203496B (de) | Verfahren zur Herstellung von neuen tertiären Aminen | |
| AT203015B (de) | Verfahren zur Herstellung von neuen 1-(p-Butoxyphenyl)-3-(p-pyridylphenyl)-2-thioharnstoffen | |
| DE1929138C3 (de) | Verfahren zur Herstellung von N hoch 1 -Benzoylphenyläthylendiaminen und ihren Salzen | |
| DE1593783A1 (de) | Verfahren zur Herstellung von 1-(2-Nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen Salzen |